ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 59 filers reported holding ATRECA INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -73.3% | 1,600 | 0.0% | 0.00% | – |
| Q2 2023 | $1,568 | -14.0% | 1,600 | 0.0% | 0.00% | – |
| Q1 2023 | $1,824 | +42.4% | 1,600 | 0.0% | 0.00% | – |
| Q4 2022 | $1,281 | -57.3% | 1,600 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 1,600 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 1,600 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 1,600 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 1,600 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -28.6% | 1,600 | -5.9% | 0.00% | – |
| Q2 2021 | $14,000 | -46.2% | 1,700 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +73.3% | 1,700 | +88.9% | 0.00% | – |
| Q4 2020 | $15,000 | -40.0% | 900 | -50.0% | 0.00% | – |
| Q3 2020 | $25,000 | -58.3% | 1,800 | -35.7% | 0.00% | – |
| Q2 2020 | $60,000 | +30.4% | 2,800 | 0.0% | 0.00% | – |
| Q1 2020 | $46,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
| EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
| Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
| Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
| CM Management, LLC | 60,000 | $969,000 | 0.90% |
| Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
| Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
| Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
| Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
| HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |